Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124926762 | 12492676 | 2 | F | 201512 | 20160817 | 20160623 | 20160822 | EXP | US-GLAXOSMITHKLINE-US2016GSK062906 | GLAXOSMITHKLINE | 74.89 | YR | F | Y | 61.00000 | KG | 20160822 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124926762 | 12492676 | 1 | SS | KEFLEX | CEPHALEXIN | 1 | Y | 0 | |||||||||||
124926762 | 12492676 | 2 | SS | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | UNK, U | U | 0 | ||||||||||
124926762 | 12492676 | 3 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), BID | U | 21077 | 1 | DF | INHALATION POWDER | BID | ||||||
124926762 | 12492676 | 4 | SS | VENTOLIN | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 5 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, BID | U | 0 | 150 | MG | BID | ||||||
124926762 | 12492676 | 6 | SS | XANAX | ALPRAZOLAM | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 7 | SS | BETAPACE | SOTALOL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 8 | SS | CORTEF | HYDROCORTISONE | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 9 | SS | LASIX | FUROSEMIDE | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 10 | SS | NITROGLYCERIN. | NITROGLYCERIN | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 11 | SS | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 12 | SS | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 13 | SS | XARELTO | RIVAROXABAN | 1 | U | 0 | |||||||||||
124926762 | 12492676 | 14 | SS | Triamcinolone | TRIAMCINOLONE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124926762 | 12492676 | 1 | Product used for unknown indication |
124926762 | 12492676 | 2 | Product used for unknown indication |
124926762 | 12492676 | 3 | Product used for unknown indication |
124926762 | 12492676 | 4 | Product used for unknown indication |
124926762 | 12492676 | 5 | Product used for unknown indication |
124926762 | 12492676 | 11 | Product used for unknown indication |
124926762 | 12492676 | 14 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124926762 | 12492676 | HO |
124926762 | 12492676 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124926762 | 12492676 | Anxiety | |
124926762 | 12492676 | Atrial fibrillation | |
124926762 | 12492676 | Chest pain | |
124926762 | 12492676 | Diarrhoea | |
124926762 | 12492676 | Drug hypersensitivity | |
124926762 | 12492676 | Dysphagia | |
124926762 | 12492676 | Dyspnoea | |
124926762 | 12492676 | Face oedema | |
124926762 | 12492676 | Fluid overload | |
124926762 | 12492676 | Headache | |
124926762 | 12492676 | Hepatic enzyme increased | |
124926762 | 12492676 | Hypertension | |
124926762 | 12492676 | Laryngeal oedema | |
124926762 | 12492676 | Nausea | |
124926762 | 12492676 | Oedema | |
124926762 | 12492676 | Pain | |
124926762 | 12492676 | Rash | |
124926762 | 12492676 | Right ventricular failure | |
124926762 | 12492676 | Urticaria | |
124926762 | 12492676 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124926762 | 12492676 | 5 | 201512 | 0 |